Hommann M - Search Results

1

Impact of mycophenolate mofetil versus azathioprine on early recurrence of hepatitis C after liver transplantation.

Kornberg A, Küpper B, Tannapfel A, Hommann M, Scheele J. Kornberg A, et al. Among authors: hommann m. Int Immunopharmacol. 2005 Jan;5(1):107-15. doi: 10.1016/j.intimp.2004.09.010. Int Immunopharmacol. 2005. PMID: 15589468 Clinical Trial.

2

Introduction of MMF in conjunction with stepwise reduction of calcineurin inhibitor in stable liver transplant patients with renal dysfunction.

Kornberg A, Küpper B, Hommann M, Scheele J. Kornberg A, et al. Among authors: hommann m. Int Immunopharmacol. 2005 Jan;5(1):141-6. doi: 10.1016/j.intimp.2004.09.018. Int Immunopharmacol. 2005. PMID: 15589474 Clinical Trial.

3

Long-term combination of interferon alfa-2b and ribavirin for hepatitis C recurrence in liver transplant patients.

Kornberg A, Hommann M, Tannapfel A, Wagner T, Grube T, Schotte U, Voigt R, Scheele J. Kornberg A, et al. Among authors: hommann m. Am J Transplant. 2001 Nov;1(4):350-5. doi: 10.1034/j.1600-6143.2001.10410.x. Am J Transplant. 2001. PMID: 12099379 Free article.

4

Impact of selective prostaglandin E1 treatment on graft perfusion and function after liver transplantation.

Kornberg A, Schotte U, Kupper B, Hommann M, Scheele J. Kornberg A, et al. Among authors: hommann m. Hepatogastroenterology. 2004 Mar-Apr;51(56):526-31. Hepatogastroenterology. 2004. PMID: 15086195

5

Prevention of early loss of bone mineral density after liver transplantation by prostaglandin E1.

Hommann M, Kämmerer D, Lehmann G, Kornberg A, Küpper B, Daffner W, Wolf G, Settmacher U. Hommann M, et al. Transplant Proc. 2007 Mar;39(2):540-3. doi: 10.1016/j.transproceed.2006.12.016. Transplant Proc. 2007. PMID: 17362777

6

Conversion to mycophenolate mofetil for modulating recurrent hepatitis C in liver transplant recipients.

Kornberg A, Küpper B, Wilberg J, Tannapfel A, Thrum K, Bärthel E, Hommann M, Settmacher U. Kornberg A, et al. Among authors: hommann m. Transpl Infect Dis. 2007 Dec;9(4):295-301. doi: 10.1111/j.1399-3062.2007.00228.x. Epub 2007 May 19. Transpl Infect Dis. 2007. PMID: 17511824 Clinical Trial.

7

Cytomegalovirus infection after liver transplantation using different prophylaxes.

Kornberg A, Grube T, Hommann M, Schotte U, Scheele J. Kornberg A, et al. Among authors: hommann m. Transplant Proc. 2001 Nov-Dec;33(7-8):3624-5. doi: 10.1016/s0041-1345(01)02559-3. Transplant Proc. 2001. PMID: 11750539 No abstract available.

8

Application of MARS artificial liver support as bridging therapy before split liver retransplantation in a 15-month-old child.

Hommann M, Kasakow LB, Geoghegan J, Kornberg A, Schotte U, Fuchs D, Hermann J, Zintl F, Scheele J. Hommann M, et al. Pediatr Transplant. 2002 Aug;6(4):340-3. doi: 10.1034/j.1399-3046.2002.02007.x. Pediatr Transplant. 2002. PMID: 12234277

9

Combination therapy/prophylaxis with interferon and ribavirin for recurrent hepatitis C after liver transplantation: long-term effects on graft function and morphology.

Kornberg A, Hommann M, Tannapfel A, Grube T, Schotte U, Scheele J. Kornberg A, et al. Among authors: hommann m. Transplant Proc. 2002 Sep;34(6):2259-60. doi: 10.1016/s0041-1345(02)03226-8. Transplant Proc. 2002. PMID: 12270389 Clinical Trial. No abstract available.

10

Cerebral toxoplasmosis after combined liver-pancreas-kidney and liver-pancreas transplantation.

Hommann M, Schotte U, Voigt R, Glutig H, Grube T, Küpper B, Kornberg A, Richter K, Scheele J. Hommann M, et al. Transplant Proc. 2002 Sep;34(6):2294-5. doi: 10.1016/s0041-1345(02)03241-4. Transplant Proc. 2002. PMID: 12270404 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

63 results

Search Page

Filters